You are here

Tanzeum

How Big Can This $8 Billion-Plus Diabetes Drug Class Get?

Motley Fool

Fri, 09/27/19 - 09:10 am

GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesn't bode well for Sanofi, AstraZeneca: analyst

Fierce Pharma

Tue, 08/1/17 - 10:48 pm

New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy

Seeking Alpha

Mon, 04/21/14 - 04:51 pm

In Case You Missed It: GlaxoSmithKline Just Had a Phenomenal Week!

Motley Fool

Fri, 04/18/14 - 04:48 pm

FDA approves Tanzeum to treat type 2 diabetes

Yahoo/Fly on the Wall

Tue, 04/15/14 - 10:34 am

type 2 diabetes